TREM2 and Alzheimer disease: Significant evidence suggests that TREM2 is a direct phagocytic receptor (Takahashi et al., 2005; N’Diaye et al., 2009), which implies that failure to phagocytose aggregated proteins is a key driver of AD and related diseases.